Clinical Care Guidance for Severe ME/CFS
1 Hermisson et al. 2026 — Transdisciplinary Expert Statement: Care Guide for Severe ME/CFS
Full Citation:: Hermisson J, Schreiner C, Weichselbaumer S, et al. Transdisziplinäres Expert:innen-Statement: Pflegeleitfaden für Menschen mit schwerem ME/CFS in der häuslichen Versorgung. Wiener Medizinische Wochenschrift. 2026. doi:10.1007/s10354-026-01155-6 DOI:: 10.1007/s10354-026-01155-6 Published:: June 1, 2026 Study Design:: Transdisciplinary consensus statement Key Findings::
- First transdisciplinary consensus-based nursing care guide specifically for severe/very severe ME/CFS — developed by Austrian Society for ME/CFS + MedUni Vienna
- Defines PEM-aware nursing as fundamentally different from standard activating care: goal is stabilization, not activation
- Introduces rolling PEM concept in clinical language — overlapping crash cycles without full stabilization
- Provides detailed protocols for body care, oral care, nutrition, mobility/transfers, communication, sensory intolerance, and emotional/existential support in bedbound patients
- Maps palliative care principles (total pain concept, radical patient orientation) to severe ME/CFS
- Addresses caregiver burden (24/7 care, secondary traumatization, financial strain, social isolation) as integral to the care plan
- Includes home visit planning protocols (pre-visit tolerance assessment, minimal-stay procedures, non-verbal communication, stop-signal establishment)Conclusion:: This is the first structured, consensus-based nursing care guide for severe ME/CFS. It provides practical, PEM-aware protocols across all care dimensions and establishes care principles (harm avoidance, stimulus reduction, minimal intervention) that differ fundamentally from standard activating nursing. Limitations:: Practice-oriented consensus document rather than systematic evidence review; primarily based on experiential knowledge from patients and caregivers with professional expert validation; no formal grading of recommendations; Austrian healthcare context may limit transferability; German language (English translation needed for international use). Certainty:: 0.85/1.0 Research Stream:: severe-mecfs-care-guide
2 Montoya et al. 2021 — Caring for the Severe/Very Severe ME/CFS Patient
Full Citation:: Montoya JG, Dowell TG, Mooney AE, Dimmock ME, Chu L. Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Healthcare (Basel). 2021;9(10):1331. DOI:: 10.3390/healthcare9101331 Key Findings::
- Comprehensive clinical guidance on caring for patients with severe/very severe ME/CFS
- Covers medical management, symptom control, and palliative approaches
- Addresses ethical considerations in severe disease managementConclusion:: Provides multi-expert clinical guidance for the most severely affected ME/CFS patients. Limitations:: Clinical expert opinion rather than systematic review; limited empirical evidence base for severe ME/CFS interventions. Certainty:: 0.75/1.0 Research Stream:: severe-mecfs-care-guide
3 Crowhurst 2005 — Supporting People with Severe ME
Full Citation:: Crowhurst G. Supporting people with severe myalgic encephalomyelitis. Nursing Standard. 2005;19(21):38–43. DOI:: 10.7748/ns2005.02.19.21.38.c3806 Key Findings::
- Foundational nursing guidance for severe ME care
- Addresses symptom management and communication strategies for bedbound patients
- Emphasizes rest as primary interventionConclusion:: Early recognition of severe ME as distinct nursing challenge requiring specialized approaches. Limitations:: Single-author perspective piece; significantly dated (2005); no systematic methodology. Certainty:: 0.55/1.0 Research Stream:: severe-mecfs-care-guide
4 Fennell et al. 2021 — Elements of Suffering in Severe ME/CFS
Full Citation:: Fennell PA, Dorr N, George SS. Elements of Suffering in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Experience of Loss, Grief, Stigma, and Trauma in the Severely and Very Severely Affected. Healthcare (Basel). 2021;9(5):553. DOI:: 10.3390/healthcare9050553 Study Design:: Qualitative study Key Findings::
- Documents four domains of suffering in severe ME/CFS: loss, grief, stigma, and trauma
- Loss: physical function, identity, relationships, future possibilities
- Grief: ambiguous loss — patient is living but former life is gone
- Stigma: medical disbelief, social invalidation, internalized shame
- Trauma: from illness experience, medical encounters, and social abandonmentConclusion:: Severe ME/CFS produces complex suffering beyond physical symptoms that requires recognition and psychosocial support. Limitations:: Qualitative methodology limits generalizability; self-selected sample. Certainty:: 0.65/1.0 Research Stream:: severe-mecfs-care-guide
5 Gaunt et al. 2024 — Graded Exercise Therapy vs Activity Management in Paediatric CFS/ME
Full Citation:: Gaunt DM, Brigden A, Harris SRS, Hollingworth W, Jago R, Solomon-Moore E, Beasant L, Mills N, Sinai P, Crawley E, Metcalfe C. Graded exercise therapy compared to activity management for paediatric chronic fatigue syndrome/myalgic encephalomyelitis: pragmatic randomized controlled trial. European Journal of Pediatrics. 2024;183(5):2343–2351. (Gaunt et al. 2024) DOI:: 10.1007/s00431-024-05458-x PMID:: 38429546 Study Design:: Pragmatic randomized controlled trial Key Findings::
- Compared graded exercise therapy (GET) with activity management in paediatric CFS/ME (MAGENTA trial)
- GET did not outperform activity management on primary outcomes
- Results align with NICE 2021 decision to withdraw GET from ME/CFS managementConclusion:: GET offers no benefit over activity management in paediatric ME/CFS and has no role in (severe) management; supports rejection of rehabilitation-based approaches. Limitations:: Paediatric population; pragmatic (non-blinded) design; specific to GET, not all activity-based approaches. Certainty:: 0.75/1.0 Research Stream:: severe-mecfs-management
6 Wearden et al. 2006 — FINE Trial Study Protocol
Full Citation:: Wearden AJ, Riste L, Dowrick C, Chew-Graham C, Bentall RP, Morriss RK, Peters S, Richardson G, Lovell K, Dunn G. Fatigue Intervention by Nurses Evaluation—the FINE Trial. A randomised controlled trial of nurse led self-help treatment for patients in primary care with chronic fatigue syndrome: study protocol. BMC Medicine. 2006;4:9. (Wearden et al. 2006) DOI:: 10.1186/1741-7015-4-9 PMID:: 16603058 Study Design:: RCT protocol (ISRCTN74156610) Key Findings::
- Designs pragmatic rehabilitation and supportive listening delivered by trained nurses vs GP treatment as usual in primary-care CFS/ME
- Home-delivered, 10 sessions over 18 weeks by three adult specialty nurses
- Primary outcomes: fatigue and physical functioning at 20 and 70 weeksConclusion:: Documents the design of the FINE intervention; results (Wearden 2010, BMJ 340:c1777) showed no sustained benefit, informing critique of rehabilitation-based approaches in (severe) ME/CFS. Limitations:: Protocol only — no results. Certainty:: 0.75/1.0 Research Stream:: severe-mecfs-management
7 Wearden et al. 2010 — FINE Trial Results
Full Citation:: Wearden AJ, Dowrick C, Chew-Graham C, Bentall RP, Morriss RK, Peters S, Riste L, Richardson G, Lovell K, Dunn G, et al. Nurse led, home based self help treatment for patients in primary care with chronic fatigue syndrome: randomised controlled trial. BMJ. 2010;340:c1777. (Wearden et al. 2010) DOI:: 10.1136/bmj.c1777 PMID:: 20418251 Study Design:: Randomized controlled trial (n=296 primary-care CFS/ME, Oxford criteria) Key Findings::
- Pragmatic rehabilitation improved fatigue only at 20 weeks (effect −1.18, P=0.021), with NO significant benefit at 70 weeks (−1.00, P=0.076)
- No significant difference in physical functioning at 70 weeks
- Supportive listening was NOT effective (worse physical functioning at 20 weeks, no difference at 70 weeks)Conclusion:: Nurse-delivered pragmatic rehabilitation yields only small short-term fatigue improvement with no sustained benefit; supportive listening is ineffective. Supports the position that rehabilitation-based approaches have no place in (severe) ME/CFS management. Limitations:: Primary-care population (Oxford criteria), not severe/very-severe cases; single-blind design. Certainty:: 0.80/1.0 Research Stream:: severe-mecfs-management
8 Devasahayam et al. 2012 — Alternative Diagnoses in CFS Referrals
Full Citation:: Devasahayam A, Lawn T, Murphy M, White PD. Alternative diagnoses to chronic fatigue syndrome in referrals to a specialist service: service evaluation survey. JRSM Short Reports. 2012;3(1):4. (Devasahayam et al. 2012) DOI:: 10.1258/shorts.2011.011127 PMID:: 22299071 Study Design:: Service evaluation survey Key Findings::
- Reviewed referrals to a specialist CFS service for alternative diagnoses
- A proportion of patients had alternative (sometimes clinically important) diagnoses misattributed to CFSConclusion:: Emphasizes the need for diagnostic thoroughness and exclusion of alternative diagnoses before attributing severe symptoms to ME/CFS, especially where severe/very-severe care is planned. Limitations:: Service evaluation (non-systematic); single specialist centre; dates from 2012. Certainty:: 0.60/1.0 Research Stream:: severe-mecfs-management
9 Page et al. 2019 — Paediatric Enteral Feeding at Home: Patient Safety
Full Citation:: Page B, Nawaz R, Haden S, Vincent C, Lee ACH. Paediatric enteral feeding at home: an analysis of patient safety incidents. Archives of Disease in Childhood. 2019;104(12):1174–1180. (Page et al. 2019) DOI:: 10.1136/archdischild-2019-317090 PMID:: 31201158 Study Design:: Patient safety incident analysis Key Findings::
- Documents risks and adverse events associated with home enteral feeding
- Identifies safety incident patterns (tube/placement, infection, aspiration, refeeding concerns)Conclusion:: Home enteral feeding requires risk-aware planning; the S4ME factsheet uses such evidence to argue enteral feeding for severe nutritional failure should be managed safely rather than delayed on ‘functional’ grounds. Limitations:: Paediatric population; incident-report-based (may under/over-report); UK context. Certainty:: 0.65/1.0 Research Stream:: severe-mecfs-management
10 McPhee et al. 2019 — Monitoring Treatment Harm in ME/CFS
Full Citation:: McPhee G, Baldwin A, Kindlon T, Hughes BM. Monitoring treatment harm in myalgic encephalomyelitis/chronic fatigue syndrome: A freedom-of-information study of NHS specialist centres in England. Journal of Health Psychology. 2019;26(7):975–984. (McPhee et al. 2019) DOI:: 10.1177/1359105319854532 PMID:: 31234662 Study Design:: Freedom-of-information study Key Findings::
- Documents that adverse effects of treatment are not systematically monitored or reported by NHS specialist ME/CFS centres in England
- Highlights gaps in harm reporting for ME/CFS treatmentsConclusion:: Treatment (including off-label drugs and rehabilitation approaches) carries risk of harm; harm monitoring must be a mandatory part of (severe) ME/CFS management — central to the factsheet’s critical appraisal stance. Limitations:: Freedom-of-information methodology (relies on what centres disclosed); England only. Certainty:: 0.70/1.0 Research Stream:: severe-mecfs-management
11 Science for ME (Edwards et al.) 2026 — Management of Severe and Very Severe ME/CFS
Full Citation:: Science for ME (Edwards J, et al.) Management of severe and very severe ME/CFS. Science for ME (S4ME) fact sheet. 2026. Science for ME (2026) Key Findings::
- Severity grading tied to care needs; ~1/1000 patients housebound
- Environmental-stimuli reduction as medical necessity (not kindness) to prevent deterioration
- Single-point-of-contact care (specialist nurse) preferred over multidisciplinary teams
- Rehabilitation-based approaches "have no place in management" (GET/CBT critique)
- Critical appraisal of off-label drugs (antihistamines, naltrexone, fludrocortisone, ivabradine): little or no benefit, likely more adverse effects
- Enteral/parenteral feeding for severe nutritional failure; MUST malnutrition screening; not to be delayed on 'functional' grounds
- Hospital admission adjustments (single room, blinds, no scent, etc.)Conclusion:: Provides practical, severity-stratified clinical management guidance for severe and very severe ME/CFS, emphasizing harm avoidance and early nutritional support. Limitations:: Advocacy/clinical-guidance fact sheet rather than primary research; not a systematic review; consensus-based. Certainty:: 0.60/1.0 Research Stream:: severe-mecfs-management